Terence Kin-Wah Lee

30PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Oct 26, 2026
Tumor-derived annexin A1 drives lenvatinib resistance by regulating SOX2/STAT3/S100A6 feedback loop and M2 macrophage polarization in hepatocellular carcinoma.

|Sep 02, 2026
p38β-mediated BiP phosphorylation drives stemness and chemoresistance by suppressing UPR activation in hepatocellular carcinoma.

|Jun 19, 2026
Chemical-Assembled Macrophage-Engaging Glypican-3 × Signal Regulatory Protein-α (SIRP-α) Bispecific Antibody for Immunotherapy Against Liver Cancer.

|Dec 25, 2025
Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.

Yasi Pan, Xiang Zhang, Chi Chun Wong

|Nov 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung

|Jul 30, 2025
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models.

Kai-Yu Ng, Tin-Yan Koo, Ianto Bosheng Huang

Pageof 5

Frequent Collaborators

16 joint publications

Stephanie Ma

7 joint publications

Tin-Lok Wong

6 joint publications

Man Tong

5 joint publications

Irene Oi-Lin Ng